Professor Kari Remes - UTU Research Portal

Kari Remes
Professor

- Docent,
Faculty of Medicine (University of Turku)

kari.remes@utu.fi

	Publications full list.pdf
	CV Remes Kari.pdf

Areas of expertise

Clinical haematology; Bone marrow transplantation

Teaching

Hematologian luennointi ja seminaarit (C6 ja C11). Hematologian ryhmäopetus (C6). Hematologisten syventävien opinnäytteiden ohjaus.

Publications

6 of 6

Central nervous system immune reconstitution inflammatory syndrome (IRIS) after hematopoietic SCT (2010)
- Bone Marrow Transplantation
Airas L, Päivärinta M, Röyttä M, Karhu J, Kauppila M, Itälä-Remes M, Remes K
(A1 Refereed original research article in a scientific journal)
Depth of response assessed by quantitative ASO-PCR predicts the outcome after stem cell transplantation in multiple myeloma (2010)
- European Journal of Haematology
Putkonen M, Kairisto V, Juvonen V, Pelliniemi T-T, Rauhala A, Itälä-Remes M, Remes K
(A1 Refereed original research article in a scientific journal)
ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation status (2010)
- European Journal of Haematology
Hämäläinen M, Juvonen V, Häikiö S, Lakkala T, Johansson J, Pelliniemi T-T, Salmi TT, Remes K, Kairisto V
(A1 Refereed original research article in a scientific journal)
Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission (2010)
- Blood
Gorin N-C, Labopin M, Reiffers J, Milpied N, Blaise D, Witz F, de Witte T, Meloni G, Attal M, Bernal T, Rocha V, for the Acute Leukemia Working Party of the European Cooperative etc, Remes K
(A1 Refereed original research article in a scientific journal)
Multiparametric flow cytometry profiling of neoplastic plasma cells in multiple myeloma (2010)
- Cytometry Part B: Clinical Cytometry
Johnsen HE, Bogsted M, Klausen TW, Gimsing P, Schmitz A, Kjaersgaard E, Damgaard T, Voss P, Knudsen LM, Mylin AK, Lanng Nielsen J, Björkstrand B, Gruber A, Lenhoff S, Remes K, Dahl IM, Fogd K, Dybkaer K, on behalf of NMSG and MSCNET
(A1 Refereed original research article in a scientific journal)
Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia (2010)
- New England Journal of Medicine
Saglio G, Kim D-W, Issaragrisil S, le Coutre P, Etienne G, Lobo C, Pasquini R, Clark RE, Hochhaus A, Hughes TP, Gallagher N, Hoenekopp A, et al., for the ENESTnd Investigators, Remes K
(A1 Refereed original research article in a scientific journal)